Drug Trial Radar · NCT06424288
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
6,712
Planned (sponsor's estimate)
Start
Jun 17, 2024
Primary completion
May 22, 2028
Study completion May 22, 2028
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- May 22, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Participants are put into 2 groups by chance. Every participant has an equal chance of being in each group. The groups are: * Vicadrostat/empagliflozin group: participants take vicadrostat/empagliflozin as tablets once a day. * Placebo/empagliflozin group: participants take placebo/empagliflozin as tablets once a day. Participants can stay in the study as long as they benefit from treatment and can tolerate it. During this time, they visit their doctors regularly. The doctors regularly check participants' health and take note of any unwanted effects. The study staff may also contact the participants by phone. Participants also regularly answer questions about their well-being. The study does not have a fixed duration. It continues until there is enough data to see if the treatment is working.
Conditions
- Heart Failure
Interventions
vicadrostatDrug
vicadrostat
empagliflozinDrug
empagliflozin
placeboDrug
placebo matching vicadrostat
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first event of Cardiovascular (CV) death, hospitalisation for heart failure (HHF) or urgent heart failure (HF) visitTime frame: up to 42 months
Locations
672 sites in 30 countries. Site status is shown where the registry gives one.
Diagnostic and Medical Clinic
Mobile, Alabama · Recruiting
Mobile Heart Specialists, PC
Mobile, Alabama · Recruiting
Velocity Clinical Research-Chula Vista
Chula Vista, California · Recruiting
University of California Irvine
Orange, California · Recruiting
North America Research Institute
San Dimas, California · Recruiting
Amicis Research Center - Valencia
Santa Clarita, California · Recruiting
Orange County Research Center
Tustin, California · Recruiting
Bridgeport Hospital
Bridgeport, Connecticut · Recruiting
Flourish Research
Boca Raton, Florida · Recruiting
Bay Area Cardiology
Brandon, Florida · Recruiting
Clearwater Cardiovascular and Interventional Consultants
Clearwater, Florida · Recruiting
Cardiology Associates Research Co.
Daytona Beach, Florida · Recruiting
Malcom Randall VA Medical Center
Gainesville, Florida · Recruiting
Velocity Clinical Research-Hallandale Beach-67888
Hallandale, Florida · Recruiting
University of Florida Health Jacksonville
Jacksonville, Florida · Recruiting
East Coast Institute for Research, LLC - Jacksonville
Jacksonville, Florida · Recruiting
First Coast Cardiovascular Institute
Jacksonville, Florida · Recruiting
Clearwater Cardiovascular Consultants-Largo-69917
Largo, Florida · Recruiting
University of Miami
Miami, Florida · Recruiting
Sacred Heart Medical Specialty Group
Miramar Beach, Florida · Recruiting
Advanced Research for Health Improvement, LLC
Naples, Florida · Not yet recruiting
Southwest Florida Research, LLC
Naples, Florida · Recruiting
Ocala Cardiovascular Research
Ocala, Florida · Recruiting
Ocala Research Institute, Inc
Ocala, Florida · Recruiting
Charlotte Cardiovascular Institute, PA
Port Charlotte, Florida · Recruiting
East Coast Institute for Research, LLC-Saint Augustine-63032
Saint Augustine, Florida · Recruiting
University of South Florida
Tampa, Florida · Recruiting
Cardiology Partners Clinical Research Institute
Wellington, Florida · Recruiting
Cozy Research LLC
Wesley Chapel, Florida · Recruiting
Flourish Research
Winter Park, Florida · Recruiting
Atlanta Clinical Research Centers
Atlanta, Georgia · Recruiting
Columbus Regional Research Institute
Columbus, Georgia · Recruiting
NSC Research Inc
Johns Creek, Georgia · Recruiting
Kootenai Medical Center
Coeur d'Alene, Idaho · Recruiting
Northwest Heart Clinical Research, LLC
Arlington Heights, Illinois · Recruiting
Illinois Masonic Hospital
Chicago, Illinois · Recruiting
Chicago Medical Research
Hazel Crest, Illinois · Recruiting
Clinical Investigation Specialists, Inc.-Libertyville-69941
Libertyville, Illinois · Recruiting
AMR Park Ridge
Park Ridge, Illinois · Recruiting
Midwest Cardiovascular Research and Education Foundation
Elkhart, Indiana · Recruiting
Showing 40 of 672 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.